세계의 채혈 시장 보고서 : 제품, 용도, 최종 용도, 지역별(2024-2032년)

The global blood collection market size reached US$ 7.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.

Blood collection involves the voluntary removal of blood from the body for laboratory analysis. It is usually collected within a hospital environment to identify metabolic, respiratory, and mixed-acid disorders. Some of the popular methods of blood collection are arterial, venipuncture and fingerstick sampling. Blood collection plays a crucial role in understanding, preventing and treating disease across hospitals and blood bank centers. The blood is extracted through automated equipment or manually and then separated into various components using the apheresis process. The blood samples can also be taken from the arm, ear, hand, and other parts of the body, depending on the requirement.

Blood Collection Market Trends:

The global blood collection market is primarily driven by the increasing number of surgical procedures performed in hospitals. Blood collection products are used in the treatment of patients undergoing chemotherapy, dialysis, organ and tissue transplantation, and complex surgeries. The growing cases of chronic and lifestyle diseases on account of sedentary lifestyles have also necessitated greater adherence to regular health checkups. This has escalated the need for blood collection as the primary mode of diagnosing diseases. Besides this, governments of several countries are taking initiatives to increase the number of blood donations and create awareness about its importance amidst the outbreak of coronavirus disease (COVID-19). Such programs are driving the blood collection market globally during the pandemic. Furthermore, technological advancements in the field of blood collection are facilitating the market growth. For instance, market players have introduced a push-button blood collection device, which can be used for testing HbA1c levels in diabetic and prediabetic patients. Other factors, including the rising cases of accidents and the adoption of preventive care and diagnostics among individuals, are further expected to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood collection market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.

Breakup by Product:

• Needles and Syringes
• Blood Collection Tubes
  • Serum-separating
  • EDTA
  • Heparin
  • Plasma-separating
• Blood Bags
• Others

Breakup by Application:

• Diagnostics
• Treatment

Breakup by End Use:

• Hospitals
• Diagnostics Centers
• Blood Banks
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, FL MEDICAL s.r.l., Greiner AG, Haemonetics Corporation, McKesson Corporation, Medtronic plc, Nipro Corporation, Qiagen N.V., Quest Diagnostics, Sarstedt AG & Co. KG and Terumo Corporation.

Key Questions Answered in This Report

• 1. What was the size of the global blood collection market in 2023?
• 2. What is the expected growth rate of the global blood collection market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global blood collection market?
• 4. What are the key factors driving the global blood collection market?
• 5. What is the breakup of the global blood collection market based on the product?
• 6. What is the breakup of the global blood collection market based on the application?
• 7. What is the breakup of the global blood collection market based on the end use?
• 8. What are the key regions in the global blood collection market?
• 9. Who are the key players/companies in the global blood collection market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Blood Collection Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Needles and Syringes
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Blood Collection Tubes
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Serum-separating
    • 6.2.2.2 EDTA
    • 6.2.2.3 Heparin
    • 6.2.2.4 Plasma-separating
  • 6.2.3 Market Forecast
• 6.3 Blood Bags
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Application

• 7.1 Diagnostics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Treatment
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End Use

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostics Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Blood Banks
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 FL MEDICAL s.r.l.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Greiner AG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Haemonetics Corporation
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 McKesson Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Medtronic plc
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Nipro Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Qiagen N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Quest Diagnostics
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Sarstedt AG & Co. KG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Terumo Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis